Dyne Therapeutics, Inc. Operating Income

Operating Income of DYN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income growth rates and interactive chart. Operating income is the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation, and cost of goods sold (COGS). Operating income–also called income from operations–takes a company's gross income, which is equivalent to total revenue minus COGS, and subtracts all operating expenses. A business's operating expenses are costs incurred from normal operating activities and include items such as office supplies and utilities. Operating income is measured before interest and tax expenses and is a good gauge of a company's operational profitability.

Highlights and Quick Summary

  • Operating Income for the quarter ending June 30, 2023 was $-66.7 Million (a 46.79% increase compared to previous quarter)
  • Year-over-year quarterly Operating Income increased by 57.85%
  • Annual Operating Income for 2022 was $-171 Million (a 13.96% increase from previous year)
  • Annual Operating Income for 2021 was $-150 Million (a 155.81% increase from previous year)
  • Annual Operating Income for 2020 was $-58.6 Million (a 324.18% increase from previous year)
  • Twelve month Operating Income ending June 30, 2023 was $-195 Million (a 7.74% increase compared to previous quarter)
  • Twelve month trailing Operating Income increased by 6.48% year-over-year
Trailing Operating Income for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
$-195 Million $-181 Million $-171 Million $-183 Million
Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income of Dyne Therapeutics, Inc.

Most recent Operating Incomeof DYN including historical data for past 10 years.

Interactive Chart of Operating Income of Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. Operating Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-66.74 $-45.46 – – –
2022 $-40.15 $-42.28 $-52.76 $-35.78 $-170.96
2021 $-51.96 $-42.77 $-30.17 $-25.13 $-150.03
2020 $-28.6 $-13.52 $-8.68 $-7.85 $-58.65
2019 $-3.63 – – – $-13.83

Business Profile of Dyne Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com